Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Change in Accured Expenses (2023 - 2026)

MBX Biosciences has reported Change in Accured Expenses over the past 4 years, most recently at -$4.9 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$4.9 million for Q1 2026, down 970.43% from a year ago — trailing twelve months through Mar 2026 was $1.4 million (down 66.64% YoY), and the annual figure for FY2025 was $6.8 million, up 114.32%.
  • Change in Accured Expenses reached -$4.9 million in Q1 2026 per MBX's latest filing, down from $4.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.5 million in Q4 2025 and bottomed at -$4.9 million in Q1 2026.
  • Median Change in Accured Expenses over the past 4 years was $177500.0 (2024), compared with a mean of $392900.0.
  • The largest annual shift saw Change in Accured Expenses surged 2293.6% in 2025 before it crashed 970.43% in 2026.
  • Over 4 years, Change in Accured Expenses stood at -$1.2 million in 2023, then soared by 82.81% to -$203000.0 in 2024, then soared by 2293.6% to $4.5 million in 2025, then crashed by 209.07% to -$4.9 million in 2026.
  • Business Quant data shows Change in Accured Expenses for MBX at -$4.9 million in Q1 2026, $4.5 million in Q4 2025, and $2.0 million in Q3 2025.